Profiling of promoter occupancy by PPARalpha in human hepatoma cells via ChIP-chip analysis.
about
Integrated physiology and systems biology of PPARαHuman SREBP1c expression in liver is directly regulated by peroxisome proliferator-activated receptor alpha (PPARalpha)Mitochondrial biogenesis and dynamics in the developing and diseased heartSignaling dynamics and peroxisomesGenomewide analyses define different modes of transcriptional regulation by peroxisome proliferator-activated receptor-β/δ (PPARβ/δ)Primary respiratory chain disease causes tissue-specific dysregulation of the global transcriptome and nutrient-sensing signaling networkAdaptation of peroxisome proliferator-activated receptor alpha to hibernation in batsCardiac lipin 1 expression is regulated by the peroxisome proliferator activated receptor γ coactivator 1α/estrogen related receptor axis.The PinkThing for analysing ChIP profiling data in their genomic contextModulation of fatty acid and bile acid metabolism by peroxisome proliferator-activated receptor α protects against alcoholic liver disease.PPARalpha: energy combustion, hypolipidemia, inflammation and cancerDietary capsaicin and antibiotics act synergistically to reduce non-alcoholic fatty liver disease induced by high fat diet in mice.Integration of genome-wide computation DRE search, AhR ChIP-chip and gene expression analyses of TCDD-elicited responses in the mouse liver.Endogenous ligands for nuclear receptors: digging deeper.Desnutrin/ATGL is regulated by AMPK and is required for a brown adipose phenotypeMaintaining ancient organelles: mitochondrial biogenesis and maturation.An Ideal PPAR Response Element Bound to and Activated by PPARα.Genome-wide profiling of liver X receptor, retinoid X receptor, and peroxisome proliferator-activated receptor α in mouse liver reveals extensive sharing of binding sitesThe Mechanism of Interferon Refractoriness During Hepatitis C Virus Infection and Its Reversal with a Peroxisome Proliferator-Activated Receptor α AgonistPeroxisome Proliferator Activated Receptor-α Association With Silent Information Regulator 1 Suppresses Cardiac Fatty Acid Metabolism in the Failing Heart.Interstrain differences in the severity of liver injury induced by a choline- and folate-deficient diet in mice are associated with dysregulation of genes involved in lipid metabolism.Transcriptional and Chromatin Regulation during Fasting - The Genomic EraTranscriptomic Analysis of Chronic Hepatitis B and C and Liver Cancer Reveals MicroRNA-Mediated Control of Cholesterol Synthesis ProgramsModeling drug- and chemical-induced hepatotoxicity with systems biology approaches.Convergent and divergent cellular responses by ErbB4 isoforms in mammary epithelial cells.Molecular Interactions between NAFLD and Xenobiotic Metabolism.PPARgene: A Database of Experimentally Verified and Computationally Predicted PPAR Target Genes.Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME.Information-dependent enrichment analysis reveals time-dependent transcriptional regulation of the estrogen pathway of toxicity.Molecular Mechanisms and Genome-Wide Aspects of PPAR Subtype Specific Transactivation.Mechanisms of genetic regulation in gene expression: examples from drug metabolizing enzymes and transporters.What model organisms and interactomics can reveal about the genetics of human obesity.Activation of Sterol Regulatory Element Binding Factors by Fenofibrate and Gemfibrozil Stimulates Myelination in Zebrafish.Role of Peroxisome Proliferator-Activated Receptor α in Diabetic Nephropathy.Multiple receptors shape the estrogen response pathway and are critical considerations for the future of in vitro-based risk assessment efforts.Nuclear receptors and nonalcoholic fatty liver disease.PPARα activation sensitizes cancer cells to epigallocatechin-3-gallate (EGCG) treatment via suppressing heme oxygenase-1.Cardiac nuclear receptors: architects of mitochondrial structure and function.PPARα-Sirt1 complex mediates cardiac hypertrophy and failure through suppression of the ERR transcriptional pathway.Biological features of core networks that result from a high-fat diet in hepatic and pulmonary tissues in mammary tumour-bearing, obesity-resistant mice.
P2860
Q24564130-D8DFA457-0946-4F13-8BEB-DEFBED2ECA29Q24606762-F6447433-FB8F-423D-9212-90021928ABE5Q26782031-48CEA2A8-8759-42EE-A36A-B0283B780166Q27007465-432DA621-FF6A-42F1-A290-CBD92EC42672Q28476779-3407F950-D848-451E-94CE-FA21D0772D91Q28534824-7686F2D3-CBE5-46F8-86BB-99AB549E0B76Q28647311-3FD64137-5498-404A-825F-70725786298BQ30426226-A53CAE16-1D1C-4649-84E3-4DAE9BD6BE79Q30540388-4CC8298A-7A76-4581-9C47-5CCC18F6A424Q33717578-0F4ADF4C-B076-4ED2-AC76-4E87772EFA2CQ33805104-356EC4BA-A07E-44BC-B2FC-D94B965A1A1CQ33888720-0DCCDEC4-A482-4CB6-A8E8-985534D2A52EQ33962508-FEDE3705-4CDE-46B1-9F59-E034B2827407Q34412495-B0C2465E-A144-46AA-BDA8-70A2EC90B63EQ35140891-1618DFA8-EE8B-45CE-8DE9-7457D339A4A9Q35645509-63DBF744-EB11-40B4-87E3-6D366708848FQ35737412-732D19DE-78B1-4598-B7A3-BB6EC2580CAEQ35739204-9142AB90-4F68-49FA-8EDB-907ECC71476BQ35814700-F971F7E8-798A-46FD-9D31-B4C9F76AB53EQ36296771-BD27E19D-B676-458F-B27E-3380688E0526Q36329819-B083644C-C0D3-45DB-9047-F018CB624AAFQ36355517-D6D70560-60A7-4357-8184-F72896D58426Q36364602-4D1E51B9-6D75-4098-9D6E-3AA76A2A41D4Q36466007-7AC2D3FB-FCFF-4C84-A670-479C865BA3FFQ36505841-9D96527A-CF07-4768-97CF-8774FD6FE91BQ36549795-4FFF09A7-6B1E-4D57-988A-3AAEFAA56648Q36829167-649BD437-9351-4467-9F09-A58A5FA7D54CQ37121662-A49408A7-EAC8-49DE-9A9B-53097FC5E94EQ37719183-A0C8D3F4-55D4-431A-9DAA-B336C9D44FB4Q37791438-D2401A4A-E5A1-4856-9E07-3CAAF77D6FE5Q37791990-EC9FE13D-7833-434D-8EEB-8C6935278ECDQ38012356-B2A354B7-1A4E-4D33-907B-A4E44585E666Q38444377-9D416FD5-C5AE-435E-983D-308A94BA783FQ38546383-530231E8-0FF1-48A2-8CE6-70C44960A8ECQ38663074-0A2CCB68-1464-40C6-B31C-9B4EE436ABB2Q38768048-1033F8A0-A16F-408F-8F23-43052EB35DDBQ39032412-22C5CEC4-8B11-4F90-8099-FD7CAABAF6A2Q39133516-0FBA64EC-BC68-47AC-A66D-9689454F754EQ39139824-D21BF262-A3F1-4894-BD4D-40CEF5182550Q39227263-D47C3FC4-6470-4D4C-9D23-7975C94D159D
P2860
Profiling of promoter occupancy by PPARalpha in human hepatoma cells via ChIP-chip analysis.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Profiling of promoter occupanc ...... cells via ChIP-chip analysis.
@en
type
label
Profiling of promoter occupanc ...... cells via ChIP-chip analysis.
@en
prefLabel
Profiling of promoter occupanc ...... cells via ChIP-chip analysis.
@en
P2093
P2860
P50
P356
P1476
Profiling of promoter occupanc ...... cells via ChIP-chip analysis.
@en
P2093
David L M van der Meer
Michael Müller
Philip J de Groot
Sacco C de Vries
Sami Väisänen
Tatjana Degenhardt
P2860
P304
P356
10.1093/NAR/GKQ012
P407
P577
2010-01-27T00:00:00Z